Doctors Note Logo

Published on: 9/23/2026

Does Medicare cover the RSV vaccine?

Yes, Medicare covers the RSV vaccine through Part D, and thanks to the Inflation Reduction Act, eligible enrollees pay $0 out of pocket with no deductible or copay. Coverage applies when the shot is recommended for you, currently adults 75 and older and adults 50 to 74 at increased risk, and Medicare Advantage plans with drug coverage follow the same rule. Part B does not cover RSV vaccination, so where you get the shot and how the pharmacy or clinic bills it can still lead to unexpected charges; there are several important factors to consider, explained below.

If you are weighing the RSV vaccine because of a cough, wheezing, fever, or shortness of breath you already have, understanding your symptoms first can help you decide whether to call your doctor today or simply schedule prevention at your next visit. Take a free, instant, online symptom check to see what your symptoms may indicate and get clear guidance on your next steps.

Last reviewed for medical accuracy: 09/23/2026

answer background

Explanation

Does Medicare Cover the RSV Vaccine?

Respiratory syncytial virus (RSV) can cause serious lung infections—especially in adults aged 60 and older or those with certain health conditions. Two new RSV vaccines (Arexvy by GSK and Abrysvo by Pfizer) received FDA approval in 2023 and the CDC’s Advisory Committee on Immunization Practices (ACIP) recommends one dose for adults 60+. If you’re on Medicare, you’re probably asking: does Medicare cover the RSV vaccine? This guide breaks down exactly how coverage works, what you may pay, and what steps to take next.


What Is RSV and Who’s at Risk?

  • RSV is a common respiratory virus that usually causes mild, cold-like symptoms.
  • In older adults and people with chronic lung or heart conditions, RSV can lead to pneumonia or bronchiolitis.
  • Each year in the U.S., RSV sends tens of thousands of adults 65+ to the hospital.
  • Symptoms include:
    • Cough, congestion, runny nose
    • Fever (not always present)
    • Wheezing or difficulty breathing
    • Fatigue, muscle aches

Older age, weakened immune systems, and underlying lung or heart disease increase the chance of severe RSV.


Newly Approved RSV Vaccines

Two RSV vaccines are now available for adults 60 and older:

  1. Arexvy (GSK)
  2. Abrysvo (Pfizer)

Both are single-dose, intramuscular injections given before RSV season (fall) and are proven to reduce RSV-related hospitalizations.


Understanding Medicare Vaccine Coverage

Medicare vaccine benefits are split between:

  • Medicare Part B (Medical Insurance)
    Covers certain vaccines that protect against illness related to your doctor visits (e.g., flu, pneumococcal, hepatitis B if at high risk, COVID-19).

  • Medicare Part D (Prescription Drug Plans)
    Covers most FDA-approved vaccines not covered under Part B. This generally includes shingles, Tdap (tetanus, diphtheria, pertussis), and now RSV vaccines for adults.

Does Medicare Cover RSV Vaccine Under Part B?

No. RSV vaccines are not on the Part B “preventive vaccine” list. Part B does not cover RSV immunization.

Does Medicare Cover RSV Vaccine Under Part D?

Yes. CMS has confirmed that RSV vaccines for adults 60+ are covered under Medicare Part D beginning January 1, 2024.
Key points:

  • You must be enrolled in a Part D plan or a Medicare Advantage (Part C) plan that includes drug coverage.
  • Your plan’s formulary will list Arexvy and Abrysvo as covered vaccines.
  • Coverage rules and cost-sharing (deductible, co-insurance, or copay) depend on your specific plan.

How RSV Vaccine Coverage Works

  1. Check Your Plan

    • Review your 2024 Part D formulary or call your plan’s customer service.
    • Ask: “Does my plan cover Arexvy or Abrysvo?”
  2. Find a Provider

    • Most retail pharmacies (e.g., CVS, Walgreens) administer RSV vaccines.
    • Your primary care doctor or local health department may also offer them.
  3. Cost Sharing

    • If you haven’t met your Part D deductible, you may pay full price until you do.
    • After deductible, you pay the plan’s usual copay or coinsurance rate.
    • Copays can range from $0 (for low-income subsidy enrollees) to $50+ depending on benefit design.
  4. Low-Income Subsidy (Extra Help)

    • Qualifying for Extra Help can reduce or eliminate your out-of-pocket cost.
    • Apply through your state Medicaid office or Social Security.
  5. Coverage Gap (“Donut Hole”)

    • If you hit the coverage gap, you may pay 25% of the vaccine cost until you reach the catastrophic phase.

Tips to Minimize Your Out-of-Pocket Cost

  • Enroll in a $0 deductible Part D plan that covers RSV vaccines.
  • Choose a plan with low copays in the vaccine tier.
  • If eligible, apply for Extra Help (reduces premiums and copays).
  • Get your vaccine at an in-network pharmacy to avoid balance billing.

Common Questions

Q: What if I only have Original Medicare (Parts A & B) and no Part D?
A: You won’t have vaccine coverage until you add a Part D plan or switch to a Medicare Advantage plan with drug coverage.

Q: Can Medicare Advantage plans refuse to cover RSV vaccines?
A: No—by law, all Medicare Advantage plans with drug benefits must cover FDA-approved vaccines recommended by ACIP, including RSV.

Q: Are RSV monoclonal antibodies (like nirsevimab) covered?
A: Currently, those are for infants and high-risk children. Adult RSV vaccines are what Medicare Part D covers for age 60+.


Next Steps: Preparing for RSV Season

  1. Review your Medicare Part D or Advantage plan’s vaccine benefits.
  2. Schedule your RSV shot before peak season (late fall).
  3. Keep records of your vaccine—carry proof in case your plan requests it.
  4. If you have symptoms this winter—cough, fever, breathing trouble—consider a
    free, online symptom check, using the doctor approved Ubie Symptom Checker
    to help decide whether you should seek immediate care.

Final Thoughts

RSV can be serious, especially for older adults and those with chronic conditions. With the CDC’s recommendation and Medicare Part D coverage in place, most beneficiaries can protect themselves with minimal cost. Remember:

  • Does Medicare cover RSV vaccine? Yes—under Part D or Advantage plans with drug coverage.
  • Shop around for a plan that offers the best vaccine tier benefits.
  • Talk to your doctor or pharmacist about timing and any health concerns.

If you experience severe symptoms—or anything life-threatening—speak to a doctor right away. Your health and peace of mind are worth it.

(References)

  • * Gomez GB, Nelson CB, Rizzo C, Shepard DS, Chaves SS. Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United States. J Infect Dis. 2022 Aug 15;226(Suppl 2):S293-S299. doi: 10.1093/infdis/jiac164. PMID: 35968865; PMCID: PMC9377036.

  • * Coates A, Sadreameli C. Updates on respiratory syncytial virus prophylaxis: the past, present and future. Curr Opin Pediatr. 2024 Jun 1;36(3):310-314. doi: 10.1097/MOP.0000000000001339. Epub 2024 Feb 13. PMID: 38351889.

  • * Fortunato F, Campanozzi A, Maffei G, Arena F, Carri VD, Rollo T, Lopalco PL, Martinelli D. Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study. Ital J Pediatr. 2024 Mar 7;50(1):45. doi: 10.1186/s13052-024-01617-w. Epub 2024 Mar 7. PMID: 38454523; PMCID: PMC10921699.

  • * Murphy A, Liu Z, De Souza HG, Chilson EL, Moucka R, Kardel P, Sheetz C, Sato R. Disparities in Respiratory Syncytial Virus Vaccine Uptake in the Medicare Fee-for-Service Population During 2023-2024 Season. J Am Geriatr Soc. 2025 Oct;73(10):3196-3202. doi: 10.1111/jgs.19610. Epub 2025 Jun 27. PMID: 40576640; PMCID: PMC12554831.

  • * Franck Z, Hofstraat S, Jonker L, Kragten L, Messina C, Fernandes RM, Bruijning-Verhagen P, PIPELINE National Coordinators. The evolving landscape of RSV immunization: Current policies and practices across Europe. Vaccine. 2026 Mar 19;76:128222. doi: 10.1016/j.vaccine.2026.128222. Epub 2026 Feb 14. PMID: 41690867.

  • * Wiegand RE, Sung HM, Zhang Y, Chavez A, Kautz A, Mak J, Najdowski M, Chen Y, Lai Y, Jiao Y, Chillarige Y, Link-Gelles R, Payne AB. Effectiveness of RSV Vaccines against RSV-Associated Thromboembolic Events. Emerg Infect Dis. 2026 Feb;32(2):246-249. doi: 10.3201/eid3202.251520. PMID: 41714840; PMCID: PMC12928231.

  • * Tate J, Bozzola E, Fiscus M, Pérez-Martín J, Sánchez Luna M, Weil Olivier C, Morris T. An implementation framework for planning an RSV immunization program for infants using the long-acting monoclonal antibody. Front Public Health. 2025;13:1585202. doi: 10.3389/fpubh.2025.1585202. Epub 2026 Feb 10. PMID: 41808783; PMCID: PMC12970533.

  • * Lloyd PC, Shah PB, Zhang HT, Shah N, Nair N, Wan Z, Hu M, Clarke TC, Chen M, Chillarige Y, Anderson SA, Forshee RA. Safety monitoring of health outcomes following RSVPreF3 + AS01 and RSVPreF vaccination among Medicare beneficiaries aged 65 years and older in the United States, 2023-2024. Vaccine. 2026 Apr 19;79:128459. doi: 10.1016/j.vaccine.2026.128459. Epub 2026 Mar 14. PMID: 41833132.

  • * Wiegand RE, Sung HM, Zhang Y, Chavez AJ, Hatfield KM, Kautz A, Mak J, Najdowski M, Chen Y, Lai Y, Jiao Y, Chillarige Y, Link-Gelles R, Payne AB. Respiratory Syncytial Virus Vaccine Effectiveness in Medicare Beneficiaries Residing in Nursing Homes. JAMA Intern Med. 2026 Aug 31. doi: 10.1001/jamainternmed.2026.3841. Epub 2026 Aug 31. PMID: 42671854; PMCID: PMC13531387.

  • * Lu Y, Smith ER, McEvoy R, Spencer MRT, Lindaas AF, Izurieta HS, Zhang Y, Zhang HT, Wagner E, Menis M, Naik NM, Steele WR, Wernecke M, Chillarige Y, Anderson SA, Forshee RA. Respiratory Syncytial Virus Vaccine Effectiveness Among US Older Adults, 2023-2024 Season. JAMA Netw Open. 2026 Sep 1;9(9):e2634788. doi: 10.1001/jamanetworkopen.2026.34788. Epub 2026 Sep 1. PMID: 42758507; PMCID: PMC13589284.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.